ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,180.74
      1.03%
      US Tech 100
      17,599.60
      1.04%
      Dow Jones
      38,852.27
      0.46%
      Brent Oil
      83.475
      0.42%
      Bitcoin
      63,461.23
      -0.84%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Hillstream BioPharma Inc (HILS)

      7. Hillstream BioPharma Inc (HILS) News

      HILS

      Hillstream BioPharma (HILS)

      Hillstream BioPharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:HILS
      DateTimeSourceHeadlineSymbolCompany
      03/22/202411:12AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
      03/22/202411:08AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:HILSHillstream BioPharma Inc
      03/21/20245:27PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
      03/21/20245:25PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HILSHillstream BioPharma Inc
      09/25/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
      09/21/20239:35AMGlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:HILSHillstream BioPharma Inc
      09/12/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
      09/11/202311:51AMGlobeNewswire Inc.Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic PruritisNASDAQ:HILSHillstream BioPharma Inc
      09/08/20232:30PMGlobeNewswire Inc.Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13NASDAQ:HILSHillstream BioPharma Inc
      08/30/20235:22PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
      08/30/20235:20PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HILSHillstream BioPharma Inc
      08/18/20235:15PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HILSHillstream BioPharma Inc
      08/11/20234:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HILSHillstream BioPharma Inc
      08/09/20238:47AMGlobeNewswire Inc.Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023NASDAQ:HILSHillstream BioPharma Inc
      07/20/20238:00AMGlobeNewswire Inc.Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215NASDAQ:HILSHillstream BioPharma Inc
      07/17/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
      07/11/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
      07/10/20238:47AMGlobeNewswire Inc.Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and BiologicsNASDAQ:HILSHillstream BioPharma Inc
      07/06/20238:30AMGlobeNewswire Inc.Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian CancersNASDAQ:HILSHillstream BioPharma Inc
      06/20/20234:55PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
      06/16/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
      05/22/20236:01AMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:HILSHillstream BioPharma Inc
      05/22/20236:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
      05/22/20236:01AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HILSHillstream BioPharma Inc
      05/16/20234:16PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HILSHillstream BioPharma Inc
      05/15/20234:23PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HILSHillstream BioPharma Inc
      05/15/20234:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
      05/15/20238:47AMGlobeNewswire Inc.Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly AndersonNASDAQ:HILSHillstream BioPharma Inc
      05/02/20234:05PMGlobeNewswire Inc.Hillstream BioPharma Announces Closing of Public Offering of Common StockNASDAQ:HILSHillstream BioPharma Inc
      05/02/20238:47AMGlobeNewswire Inc.Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry ConferencesNASDAQ:HILSHillstream BioPharma Inc
       Showing the most relevant articles for your search:NASDAQ:HILS